BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioIndustry Association Meeting Highlights Benefits of the Patent Box to Life Science Companies


5/2/2013 11:37:18 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

2 May 2013 -- Fifty life science companies discussed how the recently-introduced Patent Box can benefit their businesses and drive future jobs and growth in the UK at the BioIndustry Association's (BIA) breakfast briefing in Cambridge this morning.

Delegates heard from Nicola Baker-Munton, Chief Executive Officer, Stratagem IPM and Colin Hailey, Partner, Confluence Tax about how life science companies of all sizes can fully and practically utilise the Patent Box, a policy first proposed by the BIA in 2009.

Steve Bates, BIA Chief Executive Officer, said:

"It is clear that the Patent Box is a policy that will make a real difference to life science companies large and small and alongside R&D tax credits and the Biomedical Catalyst helps position the UK as a leading global location for the sector. Companies eligible for the Patent Box will pay a reduced rate of tax on any profits they make from intellectual property.

"The Patent Box is a practical step that encourages innovative small- and medium-sized companies in the UK to protect their intellectual property. BIA meetings like this are time effective way for companies to learn how to benefit from this new policy. The insights shared today put them ahead of the curve in knowing how to practically adopt this important measure.

"We have already seen actions from larger companies as a result of the patent Box: GlaxoSmithKline will invest £500 million in manufacturing capabilities in the UK as a result of the introduction of the policy and AstraZeneca said it was a key reason why they decided to retain R&D in the UK."

For further information, please contact Robert Winder, Head of Communications, rwinder@bioindustry.org, 020 7630 2191; mobile 07825 942 934.

BioIndustry Association

Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES